p53: The Multifaceted Roles of Covalent Modifications in Cancer

Tatiana A. Grigoreva,Angelina A. Romanova,Vyacheslav G. Tribulovich,Nikolay B. Pestov,Ruslan A. Oganov,Diana K. Kovaleva,Tatyana V. Korneenko,Nickolai A. Barlev
DOI: https://doi.org/10.3390/ph17121682
IF: 4.6
2024-12-14
Pharmaceuticals
Abstract:The p53 protein has attracted huge research interest over several decades due to its role as one of the most important tumor suppressors in mammals, which orchestrates a synchronous response from normal cells in the body to various forms of stress. The diverse cellular activities of the p53 protein are regulated mainly via its post-translational modifications (PTMs). PTMs affect p53 on several levels: at the level of the assembly of tetrameric complexes on DNA to transactivate its target genes, at the level of the assembly of tetrameric complexes on DNA to transactivate its target genes; at the level of proteolysis in the absence of stress; and on the contrary, at the level of augmented protein stability in response to stress signals. Disruptions in these regulatory mechanisms can lead to deviations from normal cellular function, boosting tumor initiation and progression. Conversely, targeted interventions in these pathways could prove beneficial for the development of antitumor therapies. Advancing our understanding of p53 modifiers and the proteins involved in its regulation equips researchers with an expanded toolkit for studying cellular processes and for developing biologically active molecules that influence p53-mediated responses.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?